Observational, Bi-directional (Prospective and Retrospective) Study for Patients With Newly Diagnosed Ovarian Cancer Stages IA to IVB, or Persistent or Recurrent Disease From January 2021; Irrespective of Histology
Clinical trial NCT07167433 · RECRUITING
Trial details
- NCT number
- NCT07167433
- Sponsor
- AstraZeneca
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2025-09-19
- Primary completion
- 2027-06-30
- Enrollment
- 250
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.